Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

Daniel Fowler; J. Hou; J. Foley; F. Hakim; J. Odom; K. Castro; C. Carter; E. Read; J. Gea-Banacloche; C. Kasten-Sportes; L. Kwak; W. Wilson; B. Levine; C. June; R. Gress; M. Bishop

doi:10.1080/146532402320776053

Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

Daniel Fowler, J. Hou, J. Foley, F. Hakim, J. Odom, K. Castro, C. Carter, E. Read, J. Gea-Banacloche, C. Kasten-Sportes, L. Kwak, W. Wilson, B. Levine, C. June, R. Gress, M. Bishop

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	429-430
Number of pages	2
Journal	Cytotherapy
Volume	4
Issue number	5
DOIs	https://doi.org/10.1080/146532402320776053
State	Published - 2002
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology
Genetics(clinical)
Cell Biology
Cancer Research
Transplantation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/146532402320776053

Cite this

Fowler, D., Hou, J., Foley, J., Hakim, F., Odom, J., Castro, K., Carter, C., Read, E., Gea-Banacloche, J., Kasten-Sportes, C., Kwak, L., Wilson, W., Levine, B., June, C., Gress, R., & Bishop, M. (2002). Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant. Cytotherapy, 4(5), 429-430. https://doi.org/10.1080/146532402320776053

Fowler, D, Hou, J, Foley, J, Hakim, F, Odom, J, Castro, K, Carter, C, Read, E, Gea-Banacloche, J, Kasten-Sportes, C, Kwak, L, Wilson, W, Levine, B, June, C, Gress, R & Bishop, M 2002, 'Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant', Cytotherapy, vol. 4, no. 5, pp. 429-430. https://doi.org/10.1080/146532402320776053

@article{970975354c944e079f9912c0ba2ddb6d,

title = "Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant",

author = "Daniel Fowler and J. Hou and J. Foley and F. Hakim and J. Odom and K. Castro and C. Carter and E. Read and J. Gea-Banacloche and C. Kasten-Sportes and L. Kwak and W. Wilson and B. Levine and C. June and R. Gress and M. Bishop",

year = "2002",

doi = "10.1080/146532402320776053",

language = "English (US)",

volume = "4",

pages = "429--430",

journal = "Cytotherapy",

issn = "1465-3249",

publisher = "Informa Healthcare",

number = "5",

}

TY - JOUR

T1 - Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

AU - Fowler, Daniel

AU - Hou, J.

AU - Foley, J.

AU - Hakim, F.

AU - Odom, J.

AU - Castro, K.

AU - Carter, C.

AU - Read, E.

AU - Gea-Banacloche, J.

AU - Kasten-Sportes, C.

AU - Kwak, L.

AU - Wilson, W.

AU - Levine, B.

AU - June, C.

AU - Gress, R.

AU - Bishop, M.

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=18744415962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744415962&partnerID=8YFLogxK

U2 - 10.1080/146532402320776053

DO - 10.1080/146532402320776053

M3 - Article

C2 - 12473212

AN - SCOPUS:18744415962

SN - 1465-3249

VL - 4

SP - 429

EP - 430

JO - Cytotherapy

JF - Cytotherapy

IS - 5

ER -

Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this